| Verified against primary record | |
| Data reported to the Commission (2023) | None; Austria keeps no separate records[1] |
|---|---|
| Implementing law | EU-Patientenmobilitatsgesetz[2] |
| National contact point | Gesundheit Osterreich GmbH, Vienna[2] |
| Prior authorisation, Directive route | Required where treatment places a significant planning, organisational or financing burden on the health system[2] |
| Prior authorisation, Regulation route | Always required for planned treatment, documented on Form S2[2] |
| Effect of not obtaining authorisation | Generally no reimbursement afterwards[2] |
| Independently reported | |
| EU patients using the Directive each year | About 200,000, under 0.05 per cent of EU citizens[3] |
| Bands apply only to the rows beneath them. Austria is the clearest case among EU member states of a country that does not keep the records the Commission’s collection asks for, so no Austrian claim counts exist for reference year 2023 in either direction. The absence is Austria’s own stated position as recorded by the Commission, not a failure to find the data. No typical cost range is given because no official Austrian source publishes prices paid by foreign patients. | |
Medical tourism in Austria cannot be quantified from Austrian sources. The European Commission records that Austria reported no figures for reference year 2023 because it keeps no separate records of cross-border healthcare cases, and Austria’s own national contact point describes the rules for patients without publishing counts of them. What can be documented is the framework: two parallel routes to treatment abroad, prior authorisation that is always required on one of them, and a general rule that without authorisation there is no reimbursement.
A reported absence
In the Commission’s collection for reference year 2023, Austria appears with no prior authorisation figures and no reimbursement figures, and the stated reason is that no separate records are kept. Austria is not among the three jurisdictions that failed to return the questionnaire; it returned it and recorded that the data do not exist.[1]
That distinction matters. A missing return may mean an administrative lapse; a return stating that no separate records are kept is a description of how the system is built. Austrian social insurance processes claims for care abroad within its general reimbursement machinery rather than as an identifiable cross-border category.[1]
Austria nonetheless appears in the Commission’s flow analysis as a destination, with the movement from Italy to Austria named among the busiest prior authorisation flows in the Union. Austria’s position as a recipient of cross-border patients is therefore visible only in other countries’ returns.[1]
The two routes
Austria’s national contact point for cross-border healthcare is Gesundheit Osterreich GmbH in Vienna, with information published on the federal health portal maintained by the ministry responsible for health. The Directive is implemented in Austrian law by the EU-Patientenmobilitatsgesetz, alongside the European coordination Regulations and the general social insurance acts that govern reimbursement claims.[2]
The contact point sets out two distinct routes. Unplanned treatment needed during a temporary stay falls under the coordination Regulation, where insured persons receive medically necessary benefits in EU, EEA and Swiss states and providers there must accept the European Health Insurance Card. Planned treatment that a patient deliberately seeks abroad is the second route, and there prior authorisation from the insurer is always required, documented on the S2 form.[2]
Under the Directive route, by contrast, prior authorisation is required only for planned treatments that place a significant planning, organisational or financing burden on the national health system, and the contact point states that other medical services can generally be used without it.[2]
This matches the Directive itself, which confines prior authorisation to care subject to planning requirements involving an overnight stay or highly specialised and cost-intensive infrastructure, treatments carrying a particular risk, and providers raising serious quality or safety concerns, and which caps reimbursement at the level of costs the home state would have assumed without exceeding the actual cost received.[5]
What an Austrian patient actually gets back
The contact point is candid about the financial outcome. The patient pays the costs personally and then receives part of them back. The amount depends on the type of treatment and on whether prior authorisation was in place, is capped at the actual costs incurred, and may differ significantly from what the patient paid. Only services included in the Austrian benefits catalogue are generally reimbursable.[2]
Where prior authorisation was not obtained, there is generally no reimbursement afterwards, although the contact point advises approaching the insurer to have the case examined. The warning that the refund may differ significantly from the amount paid is the practical core of the arrangement, and it is the reason cross-border care under these rules remains a minority route for patients who are not paying privately.[2]
The portal does not address how patients insured in other member states are treated or charged when they come to Austria. Its rules on the European Health Insurance Card describe providers in other countries rather than Austrian providers treating foreign-insured patients, so the incoming side is not covered there.[2]
What is counted elsewhere
Eurostat maintains a collection of hospital discharges of non-residents, with separate tables for in-patients, day cases, bed days and average length of stay, and its metadata, last updated on 15 December 2025, states that country of residence is reported for non-resident patients, while noting that some countries cannot supply it and instead report the hospital’s location or record the country of residence as unknown. Individual cell values for Austria were not retrievable for this article.[4]
For scale, the European Court of Auditors estimated that about 200,000 patients a year use the Directive across the Union, fewer than 0.05 per cent of EU citizens, with spending at roughly 0.004 per cent of the Union’s healthcare budget, prior authorisation applying in around 1 per cent of cases, and fewer than 20 per cent of citizens surveyed in 2015 aware of their cross-border rights.[3]
Limits of the evidence
There is no Austrian quantity in this entry, and that is the finding rather than a gap in the research. No count of Austrian patients treated abroad, of foreign patients treated in Austria, or of amounts reimbursed under either route was located, and the Commission records Austria’s own position that no separate records are kept. The description of the two routes comes from the national contact point’s public guidance rather than from the statute itself, which was not opened for this article, so the statutory detail of the EU-Patientenmobilitatsgesetz is not established here.
See also
- Medical tourism in Italy, the origin of a busy authorised flow into Austria
- Cross-border healthcare, and the two routes Austria distinguishes
- Administrative data in medical tourism research, and why undifferentiated claims cannot be counted
- Thermal tourism, a long-established form of health travel in the region
- Medical tourism statistics, including what a reported absence of data means
References
- European Commission, Directorate-General for Health and Food Safety. Data on cross-border patient healthcare following Directive 2011/24/EU, reference year 2023. 15 May 2025. Verified against primary record: the report was opened and the Austrian entry recording that no figures were reported because no separate records are kept, the list of the three jurisdictions that did not return the questionnaire, and the naming of the Italy to Austria authorisation flow were read directly. Retrieved 23 October 2026.
- Gesundheitsportal, published by the Austrian federal ministry responsible for health. Grenzuberschreitende Gesundheitsversorgung in Osterreich. Verified against primary record: the page was opened and the identification of Gesundheit Osterreich GmbH as national contact point, the naming of the EU-Patientenmobilitatsgesetz as the implementing law, the distinction between the unplanned-treatment and planned-treatment routes, the S2 requirement, the Directive-route authorisation test, the pay-first-then-partial-refund mechanism, the caps and benefits catalogue limitation, and the consequence of not obtaining authorisation were read directly. Retrieved 23 October 2026.
- European Court of Auditors. Special Report 07/2019: EU actions for cross-border healthcare. 2019. Verified against primary record: the report was opened and the annual patient estimate, the shares of citizens and of healthcare spending, the share of cases requiring prior authorisation and the 2015 awareness finding were read. Retrieved 23 October 2026.
- Eurostat. Hospital discharges and length of stay for inpatient and curative care (hlth_hosd), reference metadata. Last updated 15 December 2025. Verified against primary record: the metadata page was opened and the non-resident definition, the statement that country of residence is reported, the caveat about countries unable to supply it, and the list of non-resident tables were read. Retrieved 23 October 2026.
- European Parliament and Council. Directive 2011/24/EU, Chapter III, Articles 7 and 8. 9 March 2011. Verified against primary record: the chapter text was opened and the reimbursement rule in Article 7 and the three permitted grounds for prior authorisation in Article 8(2) were read. Retrieved 23 October 2026.
Sourcing note: this entry contains no Austrian patient or financial figure because none exists in the sources consulted, and the Commission records that Austria keeps no separate records rather than that it failed to report. No number has been estimated or carried over from another country to fill the gap. The framework is described from the national contact point’s own guidance; the implementing statute itself was not opened, and its detailed provisions are therefore not asserted here.